nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2E1—Dacarbazine—melanoma	0.235	0.348	CbGbCtD
Brompheniramine—CYP3A4—Temozolomide—melanoma	0.169	0.251	CbGbCtD
Brompheniramine—CYP2D6—Vemurafenib—melanoma	0.146	0.216	CbGbCtD
Brompheniramine—CYP3A4—Vemurafenib—melanoma	0.0928	0.138	CbGbCtD
Brompheniramine—CYP3A4—Docetaxel—melanoma	0.0318	0.0472	CbGbCtD
Brompheniramine—CHRM3—Metabolism—PTGS2—melanoma	1.98e-05	6.09e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—melanoma	1.98e-05	6.09e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ERCC2—melanoma	1.98e-05	6.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PRKCA—melanoma	1.98e-05	6.07e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CD—melanoma	1.97e-05	6.07e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.97e-05	6.06e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—melanoma	1.97e-05	6.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ERCC2—melanoma	1.96e-05	6.02e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—melanoma	1.95e-05	5.99e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAP2K1—melanoma	1.94e-05	5.98e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—melanoma	1.94e-05	5.97e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAP2K1—melanoma	1.94e-05	5.96e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CD—melanoma	1.93e-05	5.95e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.93e-05	5.94e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CD—melanoma	1.93e-05	5.94e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNA11—melanoma	1.93e-05	5.93e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CD—melanoma	1.92e-05	5.92e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—melanoma	1.92e-05	5.91e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.92e-05	5.9e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRAS—melanoma	1.92e-05	5.9e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	1.91e-05	5.88e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.91e-05	5.88e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—melanoma	1.91e-05	5.87e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	1.91e-05	5.86e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CG—melanoma	1.9e-05	5.85e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.9e-05	5.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.9e-05	5.84e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—melanoma	1.89e-05	5.81e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—FASN—melanoma	1.89e-05	5.8e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—melanoma	1.88e-05	5.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.88e-05	5.79e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—melanoma	1.88e-05	5.78e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—melanoma	1.86e-05	5.72e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—melanoma	1.86e-05	5.72e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC5A5—melanoma	1.86e-05	5.71e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGF2—melanoma	1.85e-05	5.69e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGF2—melanoma	1.84e-05	5.67e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—melanoma	1.84e-05	5.66e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK3—melanoma	1.84e-05	5.65e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGF2—melanoma	1.84e-05	5.65e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRAS—melanoma	1.84e-05	5.65e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—melanoma	1.83e-05	5.64e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGF2—melanoma	1.82e-05	5.59e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNAQ—melanoma	1.79e-05	5.51e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD44—melanoma	1.79e-05	5.51e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—melanoma	1.79e-05	5.49e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.78e-05	5.47e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK3—melanoma	1.76e-05	5.41e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MAPK1—melanoma	1.75e-05	5.37e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—melanoma	1.75e-05	5.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—melanoma	1.74e-05	5.34e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.73e-05	5.32e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MDM2—melanoma	1.73e-05	5.32e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—melanoma	1.73e-05	5.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.73e-05	5.31e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MDM2—melanoma	1.72e-05	5.3e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—melanoma	1.72e-05	5.29e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP1B1—melanoma	1.72e-05	5.29e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MDM2—melanoma	1.72e-05	5.29e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—melanoma	1.71e-05	5.26e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	1.71e-05	5.26e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—melanoma	1.71e-05	5.24e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—melanoma	1.7e-05	5.24e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MDM2—melanoma	1.7e-05	5.23e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—melanoma	1.7e-05	5.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—melanoma	1.7e-05	5.22e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—melanoma	1.69e-05	5.21e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—melanoma	1.69e-05	5.18e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—melanoma	1.68e-05	5.18e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—melanoma	1.68e-05	5.16e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.68e-05	5.16e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MAPK1—melanoma	1.67e-05	5.15e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—melanoma	1.67e-05	5.15e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.67e-05	5.14e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—melanoma	1.67e-05	5.14e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—melanoma	1.67e-05	5.13e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—melanoma	1.66e-05	5.09e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—melanoma	1.65e-05	5.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—melanoma	1.65e-05	5.07e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—melanoma	1.64e-05	5.04e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.62e-05	4.99e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—melanoma	1.62e-05	4.97e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—melanoma	1.61e-05	4.96e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—melanoma	1.61e-05	4.94e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—melanoma	1.61e-05	4.94e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—melanoma	1.6e-05	4.93e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—melanoma	1.6e-05	4.91e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—melanoma	1.59e-05	4.89e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—melanoma	1.58e-05	4.86e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—melanoma	1.58e-05	4.86e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1B—melanoma	1.58e-05	4.86e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.57e-05	4.84e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.57e-05	4.83e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—melanoma	1.56e-05	4.8e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—melanoma	1.56e-05	4.8e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.56e-05	4.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1B—melanoma	1.55e-05	4.78e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.55e-05	4.77e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—melanoma	1.55e-05	4.76e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—melanoma	1.55e-05	4.76e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—melanoma	1.55e-05	4.75e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—melanoma	1.54e-05	4.74e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—melanoma	1.54e-05	4.74e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—melanoma	1.54e-05	4.73e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—melanoma	1.54e-05	4.73e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—melanoma	1.54e-05	4.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—melanoma	1.54e-05	4.72e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—melanoma	1.53e-05	4.71e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—melanoma	1.53e-05	4.7e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—melanoma	1.52e-05	4.68e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—melanoma	1.52e-05	4.68e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—melanoma	1.52e-05	4.66e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—melanoma	1.51e-05	4.65e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—melanoma	1.51e-05	4.63e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—melanoma	1.51e-05	4.63e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—melanoma	1.5e-05	4.62e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—melanoma	1.5e-05	4.6e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—melanoma	1.49e-05	4.59e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—melanoma	1.49e-05	4.59e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—melanoma	1.49e-05	4.59e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—melanoma	1.49e-05	4.57e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—melanoma	1.49e-05	4.57e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—melanoma	1.48e-05	4.56e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—melanoma	1.48e-05	4.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—melanoma	1.47e-05	4.53e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—melanoma	1.47e-05	4.51e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—melanoma	1.47e-05	4.51e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—melanoma	1.46e-05	4.5e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—melanoma	1.46e-05	4.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—melanoma	1.46e-05	4.48e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—melanoma	1.46e-05	4.48e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—melanoma	1.46e-05	4.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—melanoma	1.45e-05	4.47e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—melanoma	1.45e-05	4.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—melanoma	1.45e-05	4.47e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—melanoma	1.45e-05	4.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—melanoma	1.45e-05	4.46e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—melanoma	1.45e-05	4.45e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKB1—melanoma	1.45e-05	4.45e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—melanoma	1.45e-05	4.44e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—melanoma	1.44e-05	4.44e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKB1—melanoma	1.44e-05	4.44e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—melanoma	1.44e-05	4.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKB1—melanoma	1.44e-05	4.42e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.43e-05	4.41e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—melanoma	1.43e-05	4.4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKB1—melanoma	1.42e-05	4.38e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—melanoma	1.42e-05	4.36e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—melanoma	1.42e-05	4.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—melanoma	1.41e-05	4.35e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—melanoma	1.41e-05	4.34e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—melanoma	1.41e-05	4.32e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—melanoma	1.4e-05	4.32e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—melanoma	1.4e-05	4.29e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—melanoma	1.37e-05	4.22e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—melanoma	1.36e-05	4.18e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—melanoma	1.35e-05	4.16e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—melanoma	1.34e-05	4.13e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—melanoma	1.34e-05	4.13e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—melanoma	1.34e-05	4.13e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—melanoma	1.31e-05	4.04e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—melanoma	1.31e-05	4.03e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—melanoma	1.31e-05	4.01e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PRKCA—melanoma	1.3e-05	4.01e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—melanoma	1.3e-05	4e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—melanoma	1.3e-05	4e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRAS—melanoma	1.3e-05	3.99e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—melanoma	1.3e-05	3.99e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRAS—melanoma	1.29e-05	3.98e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—melanoma	1.29e-05	3.97e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—melanoma	1.29e-05	3.97e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ERCC2—melanoma	1.29e-05	3.97e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRAS—melanoma	1.29e-05	3.96e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—melanoma	1.29e-05	3.96e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—melanoma	1.29e-05	3.96e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—melanoma	1.28e-05	3.94e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRAS—melanoma	1.28e-05	3.93e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—melanoma	1.26e-05	3.87e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK3—melanoma	1.24e-05	3.82e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—melanoma	1.24e-05	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK3—melanoma	1.24e-05	3.81e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK3—melanoma	1.23e-05	3.8e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK3—melanoma	1.22e-05	3.76e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—melanoma	1.22e-05	3.75e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—melanoma	1.21e-05	3.72e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—melanoma	1.2e-05	3.7e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—melanoma	1.2e-05	3.69e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—melanoma	1.2e-05	3.68e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—melanoma	1.19e-05	3.66e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—melanoma	1.19e-05	3.65e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—melanoma	1.19e-05	3.65e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—melanoma	1.18e-05	3.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAPK1—melanoma	1.18e-05	3.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—melanoma	1.18e-05	3.64e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAPK1—melanoma	1.18e-05	3.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—melanoma	1.18e-05	3.62e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAPK1—melanoma	1.17e-05	3.61e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—melanoma	1.17e-05	3.61e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—melanoma	1.17e-05	3.61e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAPK1—melanoma	1.16e-05	3.58e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—melanoma	1.16e-05	3.58e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—melanoma	1.12e-05	3.45e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—melanoma	1.12e-05	3.43e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—melanoma	1.11e-05	3.42e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—melanoma	1.11e-05	3.41e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—melanoma	1.1e-05	3.38e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—melanoma	1.05e-05	3.23e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—melanoma	1.03e-05	3.18e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—melanoma	1.03e-05	3.16e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—melanoma	1.03e-05	3.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—melanoma	1.02e-05	3.15e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—melanoma	1.02e-05	3.14e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—melanoma	1.02e-05	3.14e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—melanoma	1.02e-05	3.13e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—melanoma	1.01e-05	3.1e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—melanoma	9.96e-06	3.06e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—melanoma	9.93e-06	3.05e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—melanoma	9.89e-06	3.04e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—melanoma	9.86e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—melanoma	9.85e-06	3.03e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—melanoma	9.77e-06	3e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—melanoma	9.49e-06	2.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—melanoma	9.46e-06	2.91e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—melanoma	9.43e-06	2.9e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—melanoma	9.34e-06	2.87e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—melanoma	9.09e-06	2.79e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—melanoma	9.06e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—melanoma	9.03e-06	2.78e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—melanoma	8.97e-06	2.76e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—melanoma	8.94e-06	2.75e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—melanoma	8.88e-06	2.73e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—melanoma	8.85e-06	2.72e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—melanoma	8.57e-06	2.63e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—melanoma	8.39e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—melanoma	8.38e-06	2.58e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—melanoma	8.35e-06	2.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—melanoma	8.33e-06	2.56e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—melanoma	8.25e-06	2.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—melanoma	7.93e-06	2.44e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—melanoma	7.82e-06	2.4e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—melanoma	7.75e-06	2.38e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—melanoma	7.29e-06	2.24e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—melanoma	7.25e-06	2.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—melanoma	7.23e-06	2.22e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—melanoma	6.76e-06	2.08e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—melanoma	6.47e-06	1.99e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—melanoma	5.96e-06	1.83e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—melanoma	5.9e-06	1.82e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—melanoma	4.77e-06	1.47e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—melanoma	3.89e-06	1.2e-05	CbGpPWpGaD
